Novartis Q3 Adj. EPS $2.46 Beats $2.27 Estimate, Sales $14.522B Miss $14.582B Estimate

Novartis (NYSE:NVS) reported quarterly earnings of $2.46 per share which beat the analyst consensus estimate of $2.27 by 8.37 percent. This is a 9.33 percent increase over earnings of $2.25 per share from the same period last year. The company reported quarterly sales of $14.522 billion which missed the analyst consensus estimate of $14.582 billion by 0.41 percent. This is a 4.41 percent increase over sales of $13.909 billion the same period last year.